Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Color-Coded Markers Diagnose Disease Through Eyes

Facebook Twitter LinkedIn Email
SAN DIEGO, Aug. 17, 2012 — New fluorescent probes that change color when they encounter brain disease markers found in the eye could offer a simpler way to identify neurodegenerative disease and distinguish between closely related disorders such as Parkinson’s, Alzheimer’s and Creutzfeld-Jacobs.

Amyloids — sticky plaques of protein — mark several different but related brain diseases with overlapping symptoms. Methods for diagnosing and monitoring these disorders are not very advanced.

Among the few available diagnostics for Alzheimer’s disease are radioactive molecules that target amyloid, which can be detected in the brain using positron emission tomography, or PET scans. However, this test shows only whether amyloid has formed in the brain but does not distinguish between the various disease types.

To overcome this obstacle, scientists at the University of California, San Diego, have created several new fluorescent probes that change color depending on the type of amyloid they encounter. Because amyloids accumulate in the eyes as well as the brain, it is possible that neurodegenerative diseases could be differentially diagnosed with simple eye drops or ointment and an eye exam.

“The key trick here is that the small differences in the proteins that make up different forms of amyloid interact differently with our fluorescent probes to result in measurably different colors of the emitted light,” said Jerry Yang, who co-led the project with Emmanuel Theodorakis; both are professors of chemistry and biochemistry at the university. Christina Sigurdson from the department of pathology at UCSD’s School of Medicine was a key collaborator.

The physical properties of the pockets in the various amyloid proteins determine the color change in the fluorescent probes. The team showed that one of the probes glows yellow when marking amyloid deposits associated with prion disease, whereas the same probe glows green when it binds to tissue samples with Alzheimer’s disease.

“We think that our approach represents a significant step towards developing diagnostics to distinguish between different, but closely related, diseases where symptoms and pathological characteristics show many similarities,” Yang said. “Such capability might prove to be very important for deciding on effective treatment strategies for specific diseases.”

The team now is expanding its catalog of markers by creating probes that can discriminate between other amyloid forms. The technology has been licensed for commercial development of diagnostic tests for human neural disease.

The study appeared online this week in the Journal of the American Chemical Society.

For more information, visit:
Aug 2012
The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
AlzheimersAmericasamyloidamyloid depositsamyloid proteinBasic SciencebiomarkersBiophotonicsbrain diseasebrain disease markersCaliforniaChristina SigurdsonCreutzfeld-JacobsEmmanuel Theodorakisfluorescent markersfluorescent probesindustrialJerry Yangneurodegenerative disease diagnosisParkinson’sPET scanphotonicspositron emission tomographyResearch & TechnologyTest & MeasurementUniversity of California San Diego

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.